Memantine hydrochloride: a drug to be repurposed against Chikungunya virus?

被引：0
|
作者：
Anna Karla dos Santos Pereira
Igor A. Santos
Washington W. da Silva
Flávia A. Resende Nogueira
Fernando R. G. Bergamini
Ana Carolina G. Jardim
Pedro P. Corbi
机构：
[1] University of Campinas-UNICAMP,Institute of Chemistry
[2] Federal University of Uberlândia,Laboratory of Virology, Institute of Biomedical Sciences
[3] University of Araraquara-UNIARA,Department of Biological and Health Sciences
[4] Federal University of Uberlândia,Laboratory of Synthesis of Bioinspired Molecules, Institute of Chemistry
来源：
Pharmacological Reports | 2021年 / 73卷
关键词：
Chikungunya virus; Drug; Repurposing; Memantine hydrochloride; Antiviral;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：954 / 961
页数：7
相关论文
共 50 条
  • [21] Antifungal activity of the repurposed drug disulfiram against Cryptococcus neoformans
    Peng, Min
    Zhang, Chen
    Duan, Yuan-Yuan
    Liu, Hai-Bo
    Peng, Xin-Yuan
    Wei, Qian
    Chen, Qi-Ying
    Sang, Hong
    Kong, Qing-Tao
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [22] In silico prediction and analysis of CTL epitopes of Chikungunya virus proteins for vaccine candidate against Chikungunya Virus
    Kumari, K.
    Kumar, J.
    Kumar, R.
    Kumar, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 355 - 355
  • [23] Convenient Synthesis of Memantine Hydrochloride
    Ivleva, Elena A.
    Klimochkin, Yuri N.
    ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 2017, 49 (02) : 155 - 162
  • [24] An Improved Synthesis of Memantine Hydrochloride
    Binh Duong Vu
    Ngoc Minh Ho Ba
    Hung Van Tran
    Dinh Chau Phan
    ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 2020, 52 (05) : 463 - 467
  • [25] Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study
    Davuluri, Kusuma Sai
    Ghanghav, Rajnandini
    Ahire, Gunwant
    Kakade, Mahadeo
    Cherian, Sarah
    Alagarasu, Kalichamy
    Parashar, Deepti
    VIROLOGY JOURNAL, 2024, 21 (01)
  • [26] Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study
    Kusuma Sai Davuluri
    Rajnandini Ghanghav
    Gunwant Ahire
    Mahadeo Kakade
    Sarah Cherian
    Kalichamy Alagarasu
    Deepti Parashar
    Virology Journal, 21
  • [27] Recent Progress in Vaccine Development Against Chikungunya Virus
    Gao, Shan
    Song, Siqi
    Zhang, Leiliang
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [28] Exploring the antiviral activities of the FDA-approved drug sulfadoxine and its derivatives against Chikungunya virus
    Martins, Daniel Oliveira Silva
    Ruiz, Uriel Enrique Aquino
    Santos, Igor Andrade
    Oliveira, Igor Santos
    Guevara-Vega, Marco
    de Paiva, Raphael Enoque Ferraz
    Abbehausen, Camilla
    Sabino-Silva, Robinson
    Corbi, Pedro Paulo
    Jardim, Ana Carolina Gomes
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 1147 - 1159
  • [29] Construction and immunogenicity of an mRNA vaccine against chikungunya virus
    Liu, Jingjing
    Lu, Xishan
    Li, Xingxing
    Huang, Weijin
    Fang, Enyue
    Li, Wenjuan
    Liu, Xiaohui
    Liu, Minglei
    Li, Jia
    Li, Ming
    Zhang, Zelun
    Song, Haifeng
    Ying, Bo
    Li, Yuhua
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Antiviral activity of nobiletin against chikungunya virus in vitro
    Lin, Shih-Chao
    Chen, Mei-Chun
    Li, Shiming
    Lin, Chi-Chen
    Wang, Tony T.
    ANTIVIRAL THERAPY, 2017, 22 (08) : 689 - 697
12345